glp-1 dexcom ADA: CGM shows benefit in non-insulin diabetes patients GLP-1 and CGM: Why Ozempic

Is it safe to drink alcohol while using tirzepatide

All pricing remains flat across dosage levelspatients never pay more as their dose increases, removing a common barrier to adequate treatment

Cellular Migration Studies Fibroblasts and immune cells are considered central to tissue recovery

A separate study demonstrated dose-dependent increases in longitudinal bone growth from 42 microns/day in controls to 52 microns/day at the highest dose (450 mcg/day)

Published online April 18, 2025

A patient who failed progestin therapy might respond when GLP-1 agonism restores the receptor expression those progestins need to work